The Discounted Cash Flow (DCF) valuation of VBI Vaccines Inc (VBIV) is (71,889.59) USD. With the latest stock price at 0.07 USD, the upside of VBI Vaccines Inc based on DCF is -110091356.5%.
Based on the latest price of 0.07 USD and our DCF valuation, VBI Vaccines Inc (VBIV) is a sell. selling VBIV stocks now will result in a potential gain of 110091356.5%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 11.2% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (465,774.77) - (39,251.46) | (71,889.59) |
| Upside | -713284584.6% - -60109526.0% | -110091356.5% |